Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 544.51 USD | +0.21% |
|
-1.62% | -6.50% |
| 22/07 | BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542 | MT |
| 21/07 | Madrigal Pharmaceuticals Insider Sold Shares Worth $1,368,253, According to a Recent SEC Filing | MT |
| Market Cap | 1.26TCr 1.1TCr 1.03TCr 940.95Cr 1.77TCr 1,20900Cr 1.8TCr 12TCr 4.76TCr 59TCr 4.71TCr 4.61TCr 2,05500Cr | P/E 2026 * |
-74.4x | P/E 2027 * | 63.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.2TCr 1.06TCr 983.34Cr 902.34Cr 1.7TCr 1,15900Cr 1.72TCr 12TCr 4.56TCr 57TCr 4.52TCr 4.42TCr 1,97100Cr | EV / Sales 2026 * |
8.03x | EV / Sales 2027 * | 5.27x |
| Free-Float |
94.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +0.21% | ||
| 1 week | -1.62% | ||
| Current month | +1.41% | ||
| 1 month | +6.82% | ||
| 3 months | +6.27% | ||
| 6 months | +13.33% | ||
| Current year | -6.50% |
| 1 week | 526.6 |  | 555.05 |
| 1 month | 505.63 | | 569.44 |
| Current year | 416.21 | | 598.79 |
| 1 year | 286.44 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Sell | Chief Executive Officer | -2,500 | 0.0108% | ||
| 17/06/26 | Free | Director | 1,220 | 0.0053% | ||
| 17/06/26 | Baker Bros. Advisors LP
| Free | Company | 4,880 | 0.0212% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -1.62% | +82.01% | +164.74% | 1.26TCr | |
| +0.93% | +6.97% | +62.83% | +67.97% | 5.73TCr | |
| -1.92% | +6.03% | +43.68% | +84.56% | 5.5TCr | |
| -0.46% | -1.29% | +3.28% | +422.58% | 2.32TCr | |
| -2.97% | -2.35% | -22.03% | -16.54% | 2.26TCr | |
| -0.36% | +5.73% | +30.99% | -3.58% | 2.05TCr | |
| -1.34% | +0.51% | +25.02% | -30.27% | 1.76TCr | |
| -1.44% | +5.67% | +32.54% | +544.11% | 1.57TCr | |
| -1.30% | -5.02% | +165.62% | +291.37% | 1.45TCr | |
| -0.50% | -0.98% | +23.62% | +178.38% | 1.39TCr | |
| Average | -0.92% | +0.99% | +44.76% | +170.33% | 2.53TCr | |
| Weighted average by Cap. | -0.82% | +1.91% | +43.21% | +137.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 149.84Cr 131.61Cr 122.39Cr 112.31Cr 211.02Cr 14TCr 214.28Cr 1.45TCr 567.82Cr 7.09TCr 562.51Cr 550.39Cr 25TCr | 217.96Cr 191.44Cr 178.03Cr 163.37Cr 306.95Cr 21TCr 311.69Cr 2.11TCr 825.94Cr 10TCr 818.23Cr 800.59Cr 36TCr |
| Net income | -21Cr -18Cr -17Cr -16Cr -30Cr -2.02TCr -30Cr -203.31Cr -79Cr -992.44Cr -79Cr -77Cr -3.43TCr | 26Cr 23Cr 22Cr 20Cr 37Cr 2.54TCr 38Cr 255.93Cr 100Cr 1.25TCr 99Cr 97Cr 4.32TCr |
| Net Debt | -52Cr -45Cr -42Cr -39Cr -73Cr -4.96TCr -74Cr -499.66Cr -195.21Cr -2.44TCr -193.39Cr -189.22Cr -8.43TCr | -107.6Cr -95Cr -88Cr -81Cr -151.53Cr -10TCr -153.87Cr -1.04TCr -407.74Cr -5.09TCr -403.93Cr -395.23Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $544.51 | +0.21% | 1,47,390 |
| 23/26/23 | $543.35 | +1.06% | 1,60,514 |
| 22/26/22 | $537.65 | -1.67% | 3,10,899 |
| 21/26/21 | $546.79 | +2.07% | 2,22,279 |
| 20/26/20 | $535.69 | -3.21% | 2,23,809 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
